AMGEN's Repatha shows 29% cardiovascular event reduction in diabetes study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. SPY
4. ABBV
5. META
6. ACN
7. BLZE
8. IBM
9. NKE
10. MU

Go back to AMGEN's Repatha shows 29% cardiovascular event reduction in diabetes study
Amgen Inc (NASDAQ: AMGN) Delayed: 347.01 --0 (-0%)
Previous Close $347.01    52 Week High $176.85 
Open $347.01    52 Week Low $133.64 
Day High $347.01    P/E 52.26 
Day Low $347.01    EPS $6.64 
Volume 1,279